Terms: = Prostate cancer AND BIRC3, AIP1, 330, ENSG00000023445, HIAP1, Q13489, MIHC, CIAP2, API2, cIAP2, MALT2, hiap-1, RNF49, HAIP1 AND Clinical Outcome
4 results:
1. clinical outcome of prostate cancer Patients with Germline DNA Repair Mutations: Retrospective Analysis from an International Study.
Mateo J; Cheng HH; Beltran H; Dolling D; Xu W; Pritchard CC; Mossop H; Rescigno P; Perez-Lopez R; Sailer V; Kolinsky M; Balasopoulou A; Bertan C; Nanus DM; Tagawa ST; Thorne H; Montgomery B; Carreira S; Sandhu S; Rubin MA; Nelson PS; de Bono JS
Eur Urol; 2018 May; 73(5):687-693. PubMed ID: 29429804
[TBL] [Abstract] [Full Text] [Related]
2. Effects of functional genetic polymorphisms in the CYP19A1 gene on prostate cancer risk and survival.
Kanda S; Tsuchiya N; Narita S; Inoue T; Huang M; Chiba S; Akihama S; Saito M; Numakura K; Tsuruta H; Satoh S; Saito S; Ohyama C; Arai Y; Ogawa O; Habuchi T
Int J Cancer; 2015 Jan; 136(1):74-82. PubMed ID: 24803183
[TBL] [Abstract] [Full Text] [Related]
3. Appropriateness of prostate-specific antigen testing.
Poteat HT; Chen P; Loughlin KR; Winkelman JW; Allada R; Ma'luf N; Tanasijevic MJ; Bates DW
Am J Clin Pathol; 2000 Mar; 113(3):421-8. PubMed ID: 10705824
[TBL] [Abstract] [Full Text] [Related]
4. Short-term tissue culture of prostatic carcinoma samples provides useful biological parameters related to patient prognosis.
Bologna M; Vicentini C; Festuccia C; Muzi P; Napolitano T; Biordi L; Miano L
Eur Urol; 1988; 15(3-4):243-7. PubMed ID: 3215259
[TBL] [Abstract] [Full Text] [Related]
